Portfolio

Ambit Biosciences

Ambit Biosciences

Biopharmaceutical company engaged in the discovery and development of small molecule kinase inhibitors for the treatment of cancer, inflammatory disease, and other indications

Applied Genetic Technologies Corp.

Applied Genetic Technologies Corp.

Gene therapy company focused on the research and development of novel therapeutics for patients with unmet medical needs utilizing AGTC's proprietary, non-pathogenic adeno-associated virus (AAV) delivery system

Catabasis

Catabasis

Biopharmaceutical company dedicated to the discovery and development of innovative medicines to treat inflammatory and metabolic diseases

Cerapedics

Cerapedics

Spine-focused company developing a biological medical device for enhancement of cervical spine fusion

Coferon Inc.

Coferon Inc.

Drug development company focused on epigenetics (with targets in oncology and immune disorders) and infectious disease utilizing a proprietary self-assembling dimeric chemistry platform

Corridor Pharmaceuticals

Corridor Pharmaceuticals

Biopharmaceutical company that focuses on arginase inhibition to promote endothelial function

Elusys Therapeutics

Elusys Therapeutics

Biopharmaceutical company focused on the development of antibody therapeutics for the treatment of life-threatening diseases

Hydra Biosciences

Hydra Biosciences

Biopharmaceutical company that develops drugs to treat pain, inflammation, cardiovascular, and other diseases using its expertise in novel ion channels

Inotek Pharmaceuticals

Inotek Pharmaceuticals

Biopharmaceutical firm focused on the development of innovative drug candidates to address significant diseases of the eye, with a major focus on glaucoma

NeuProtect

NeuProtect

NeuProtect Pty Ltd is a life sciences start-up company based in Melbourne, Australia. NeuProtect is developing proprietary cardioprotectant and neuroprotectant small molecules to reduce tissue damage following a heart attack or stroke

NKT Therapeutics

NKT Therapeutics

Biotechnology company focused on developing therapeutics based on unique immune cells called natural killer T (NKT) cells

Synovex

Synovex

Biotechnology company developing novel antibody therapeutic for rheumatoid arthritis and other indications

VaxInnate

VaxInnate

Biotechnology company developing novel, proprietary vaccines for infectious diseases

VentiRx Pharmaceuticals

VentiRx Pharmaceuticals

Biopharmaceutical company committed to the development and commercialization of novel medicines for the treatment of cancer, respiratory, and autoimmune diseases

Xencor

Xencor

Biotechnology company that focuses on antibody engineering to significantly improve antibody half-life, immune-regulatory function and potency

The links in this section will take you to web sites maintained by third parties. All content on the third party sites is the responsibility of the owners of the sites, including protection of your privacy, which is governed by the privacy policy of those sites. We encourage you to read the Privacy Policy of every web site you visit.